External Validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score

Urology

Volumn 72, Issue 2, 2008, Pages 396-400

  Zhao, Kevin H ^a   Hernandez, David J ^a   Han, Misop ^a   Humphreys, Elizabeth B ^a   Mangold, Leslie A ^a   Partin, Alan W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL VALIDITY; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; KATTAN NOMOGRAM; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; SURVIVAL RATE; UNIVERSITY OF CALIFORNIA SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE;

CALIFORNIA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 48349127426     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.11.165     Document Type: Article

References (13)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Kattan M.W., Eastham J.A., Stapleton A.M., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
3. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
4. Cooperberg M.R., Pasta D.J., Elkin E.P., et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment Score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 173 (2005) 1938-1942
5. Lubeck D.P., Litwin M.S., Henning J.M., et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. Urology 48 (1996) 773-777
6. Cooperberg M.R., Freedland S.J., Pasta D.J., et al. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer 107 (2006) 2384-2391
7. Freedland S.J., Amling C.L., and Dorey F. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60 (2002) 670-674
8. Hall G.S., Kramer C.E., and Epstein J.I. Evaluation of radical prostatectomy specimens: a comparative analysis of sampling methods. Am J Surg Pathol 16 (1992) 315-324
9. Bova G.S., Fox W.M., and Epstein J.I. Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol 6 (1993) 201-207
10. Briganti A., Chun F.K., Hutterer G.C., et al. Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol 52 (2007) 733-743
11. Graefen M., Ohori M., Karakiewicz P.I., et al. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcomes for clinically localized prostate cancer. J Urol 171 (2004) 200-203
12. Ross P.L., Scardino P.T., and Kattan M.W. A catalog of prostate cancer nomograms. J Urol 165 (2001) 1562-1568
13. Froom P., and Froom J. Selection bias in using data from one population to another: common pitfalls in the interpretation of medical literature. Theor Med 13 (1992) 255-259